MoneyWorks4Me

clarification sought from Lupin

25 Jul 2015 Evaluate

The Exchange had sought clarification from Lupin with respect to news article appearing in The Economic Times on July 24, 2015 titled ‘Lupins Goa Unit Comes Under USFDA Scanner’. Lupin replied that the observations have already been complied with and accordingly responded to the USFDA.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..